Skip to Main Content

Paper Details

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Climacteric
2
2021
HSDD, Hypoactive Sexual Desire Disorder, Patients, Testosterone, Women, androgen, hypoactive sexual desire disorder, patients, testosterone, women
Author NameAffiliation
Sharon J ParishWeill Cornell Medical College
James A SimonGeorge Washington University School of Medicine
Susan R DavisSchool of Public Health and Preventive Medicine, Monash University
Susan R DavisSchool of Public Health and Preventive Medicine, Monash University
Annamaria GiraldiSexological Clinic
Annamaria GiraldiUniversity of Copenhagen
Irwin GoldsteinAlvarado Hospital
Irwin Goldstein
Sue W Goldstein
Noel N KimInstitute for Sexual Medicine
Sheryl A KingsbergUniversity Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine
Abraham MorgentalerBeth Israel Deaconess Medical Center, Harvard Medical School
Rossella E NappiCenter for Reproductive Medicine, IRCCS S. Matteo Foundation, University of Pavia
Kwangsung ParkChonnam National University Medical School
Cynthia A Stuenkeluniversity of california san diego School of Medicine
Abdulmaged M TraishBoston University School of Medicine
Linda VignozziDepartment of "Excellence" Experimental and Clinical Biomedical Sciences "Mario Serio", Careggi Hospital-University of Florence
Linda VignozziConsorzio Interuniversitario I.N.B.B.
  • 1 - 18

Datasets

Release 1.2